Steve Jobs succumbed to a rare pancreatic neuroendocrine tumor. This cancer type differs significantly from common pancreatic ...
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response Pancreatic ...
Pancreatic adenocarcinoma is by far the most common subtype of pancreatic cancer, but there are many other subtypes. Your pancreas is an organ behind your stomach that helps with digestion and hormone ...
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our ...
News-Medical.Net on MSN
Rare case of pancreatic Hodgkin lymphoma is often misdiagnosed as pancreatic adenocarcinoma
A new case report was published in Volume 12 of Oncoscience on October 6, 2025, titled "A peculiar case of primary lymphoma of pancreas: A rare presentation of Hodgkin lymphoma." ...
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in metastatic pancreatic cancer. Tumor-treating fields (TTFields) improve overall ...
The abstract, titled “Data-driven subtyping and differential glufosfamide benefit in pancreatic adenocarcinoma,” will be featured in Poster Session B on January 9. It will also be published in the ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer Our data showed that the ...
DENVER & SAN DIEGO--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback